Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05478213 · ClinicalTrials.gov registry record · NA
Ventricular Tachycardia Mechanisms
A NA study of Ventricular Tachycardia, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 3
- Study locations
NCT05478213: Recruiting NA study of Ventricular Tachycardia, sponsored by Emory University.
NCT05478213 is a NA study of Ventricular Tachycardia that is actively recruiting participants, run by Emory University. The registered enrollment target is 10 participants, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05478213, a NA study of Ventricular Tachycardia, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.
Primary Outcome
Identification of sites that are critical to reentry of ventricular tachycardia from bystander sites will be performed by analyzing local ventricular activation. Local ventricular action is assessed with waveform morphology and is measured in voltage (mV). The normal range is \>3 mV bipolar and \>8.3 mV unipolar.
Conditions Studied
Interventions
- DEVICE Monophasic Action Potential (MAP) Catheter
Study Locations (3)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory Clinic - Atlanta
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT05478213 shows while recruiting
NCT05478213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Monophasic Action Potential (MAP) Catheter is the first listed.
NCT05478213 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05478213 about?
NCT05478213 is a clinical study titled "Ventricular Tachycardia Mechanisms". The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart ...
What is the current status of trial NCT05478213?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-10-25. Estimated completion is 2026-05.
What conditions does trial NCT05478213 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT05478213?
The interventions under investigation include: Monophasic Action Potential (MAP) Catheter (DEVICE).
Who is sponsoring clinical trial NCT05478213?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05478213 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05478213's enrollment target sits among peer trials
10 29th of 28 the lowest of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI